What is Bortezomib-thalidomide-dexamethasone (VTd)?

Category: Prescription Drugs


See also: Bortezomib Thalidomide

Bortezomib-thalidomide-dexamethasone, also known as VTd, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents bortezomib and thalidomide along with dexamethasone, a corticosteroid.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with Bortezomib-thalidomide-dexamethasone (VTd)

Side effect Patients
Numbness in feet 1

Why patients stopped taking Bortezomib-thalidomide-dexamethasone (VTd)

Multiple reasons could be selected

Reason Patients
Course of treatment ended 2
See all 2 patients who've stopped taking Bortezomib-thalidomide-dexamethasone (VTd)


Currently taking Bortezomib-thalidomide-dexamethasone (VTd)

Duration Patients
5 - 10 years 1

Stopped taking Bortezomib-thalidomide-dexamethasone (VTd)

Duration Patients
1 - 6 months 1
6 months - 1 year 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Bortezomib-thalidomide-dexamethasone (VTd).